Breaking News, Financial News

Financial Report: Patheon 3Q

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Patheon 3Q Revenues: $195.0 million (+18%) 3Q Loss: $14.7 million (loss of $63.1 million in 3Q07) YTD Revenues: $545.1 million (+15%) YTD Loss: $38.3 million (loss of $87.1 million YTD07) Comments: Commercial Manufacturing revenues were up 15% to $157.3 million driven by strong growth in the European business. Revenue increased at all North America locations except Cincinnati, which was impacted by customer related raw material supply constraints. Pharmaceutical Development Servic...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters